Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Soldan

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Vaccine|February 23, 2011
Modelling borderline and mild dysplasia associated with HPV 6 and 11 infectionRuth Chapman, Kate Soldan, Mark Jit
Sexually Transmitted Infections|February 7, 2019
Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017Marta Checchi, David Mesher, Hamish Mohammed, et al.
BMJ (Clinical Research Ed.)|May 15, 2024
Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational studyMilena Falcaro, Kate Soldan, Busani Ndlela, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 26, 2019
Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in EnglandIrenjeet Bains, Yoon Hong Choi, Kate Soldan, et al.
International Journal of Epidemiology|September 24, 2025
Evaluating the effectiveness of the human papillomavirus vaccination programme in England, using a regression discontinuity designIsobel L Ward, Charlotte R Bermingham, Kate Soldan, et al.
Journal of Epidemiology and Community Health|December 23, 2024
Are there any sociodemographic factors associated with non-uptake of HPV vaccination of girls in high-income countries with school-based vaccination programmes? A systematic reviewEmily Dema, Roeann Osman, Kate Soldan, et al.
Sexually Transmitted Infections|March 11, 2017
Attendance of MSM at Genitourinary Medicine services in England: implications for selective HPV vaccination programme (a short communication)Jake Bayley, David Mesher, Tom Nadarzynski, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Inequalities in adolescent HPV, Td/IPV and MenACWY vaccination coverage by socio-economic status: an ecological study, England, 2017 to 2024Muhammad Ibaad Alvi, Laura Viviani, Susan Hopkins, et al.
BMJ Open|February 13, 2016
Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional studyDavid Mesher, Kavita Panwar, Sara L Thomas, et al.
British Journal of Cancer|March 29, 2022
The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilotMatejka Rebolj, Francesca Pesola, Christopher Mathews, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Vaccine|February 23, 2011
Modelling borderline and mild dysplasia associated with HPV 6 and 11 infectionRuth Chapman, Kate Soldan, Mark Jit
Sexually Transmitted Infections|February 7, 2019
Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017Marta Checchi, David Mesher, Hamish Mohammed, et al.
BMJ (Clinical Research Ed.)|May 15, 2024
Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational studyMilena Falcaro, Kate Soldan, Busani Ndlela, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 26, 2019
Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in EnglandIrenjeet Bains, Yoon Hong Choi, Kate Soldan, et al.
International Journal of Epidemiology|September 24, 2025
Evaluating the effectiveness of the human papillomavirus vaccination programme in England, using a regression discontinuity designIsobel L Ward, Charlotte R Bermingham, Kate Soldan, et al.
Journal of Epidemiology and Community Health|December 23, 2024
Are there any sociodemographic factors associated with non-uptake of HPV vaccination of girls in high-income countries with school-based vaccination programmes? A systematic reviewEmily Dema, Roeann Osman, Kate Soldan, et al.
Sexually Transmitted Infections|March 11, 2017
Attendance of MSM at Genitourinary Medicine services in England: implications for selective HPV vaccination programme (a short communication)Jake Bayley, David Mesher, Tom Nadarzynski, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 16, 2026
Inequalities in adolescent HPV, Td/IPV and MenACWY vaccination coverage by socio-economic status: an ecological study, England, 2017 to 2024Muhammad Ibaad Alvi, Laura Viviani, Susan Hopkins, et al.
BMJ Open|February 13, 2016
Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional studyDavid Mesher, Kavita Panwar, Sara L Thomas, et al.
British Journal of Cancer|March 29, 2022
The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilotMatejka Rebolj, Francesca Pesola, Christopher Mathews, et al.
Pageof 7